Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Bertrand Kaper

Orthopaedic Surgery Scottsdale, AZ Medical Doctor

NPI 1164497723 CMS profile 143232

20401 N 73Rd St Ste 135, Scottsdale, AZ 85255

Open in the dashboard

General payments

$481,705

454 records reported · program years 2019–2025

Research payments

$1,980

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$85,640 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Bertrand Kaper of Scottsdale, AZ is reported in the CMS Open Payments database as having received $481,705 across 454 general payments and $1,980 in research payments paid to them. Separately, studies naming them as principal investigator received $85,640 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $68,525 66
2024 General $80,980 72
2023 General $53,671 68
2022 General $64,160 56
2021 General $35,748 48
2020 General $37,700 39
2019 General $140,922 105
2019 Research $1,980 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bertrand Kaper
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Bertrand Kaper were reported at $68,525. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Bertrand Kaper Orthopaedic Surgery median Middle half National median
2019 $140,922 $644 $140–$2,844 $163
2020 $37,700 $312 $75–$1,860 $114
2021 $35,748 $520 $117–$2,495 $132
2022 $64,160 $598 $128–$2,731 $149
2023 $53,671 $461 $128–$2,264 $160
2024 $80,980 $497 $134–$2,475 $164
2025 $68,525 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $453,109 408 payments
  2. Avanos Medical $24,840 19 payments
  3. Heron Therapeutics, Inc. $2,393 2 payments
  4. Zimmer Biomet Holdings, Inc. $817 3 payments
  5. Davol Inc. $147 2 payments
  6. Abbott Laboratories $46 2 payments
  7. Onkos Surgical, Inc. $44 2 payments
  8. Stryker Corporation $42 2 payments
  9. Djo, LLC $40 1 payment
  10. Pacira Pharmaceuticals Incorporated $33 2 payments
  11. Other $193 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $210,461 64 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $196,088 79 payments
  3. Travel and Lodging $42,942 112 payments
  4. Honoraria $22,627 7 payments
  5. Food and Beverage $8,954 191 payments
  6. Education $633 1 payment
Products named General payments · program years 2019–2025
  1. REAL INTELLIGENCE $207,456 151 payments
  2. JOURNEY II Recon Knees $128,259 57 payments
  3. Navio Surgical System $125,192 89 payments
  4. Journey II XR $73,097 47 payments
  5. LEGION Revision $68,633 39 payments
  6. Journey II BCS $60,664 35 payments
  7. JII Unicondylar Knee System $58,890 33 payments
  8. JOURNEY II Recon Knees $51,221 16 payments
  9. JOURNEY II Recon Knees $42,326 13 payments
  10. JOURNEY II Recon Knees $40,628 26 payments
  11. Other $443,464 352 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Smith+Nephew, Inc. $1,980 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

39

Median for Orthopedic Surgery: 203

Drug cost

$33

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 39 $33

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 44 billing codes

Paid by Medicare

$469,658

Medicare's payments for the services billed

Medicare patients

820

Average age 75

Services billed

1,548

494 women, 326 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 67%
Ischemic heart disease 26%
Osteoporosis 24%
Depression 19%
Chronic kidney disease 17%
Diabetes 15%
Atrial fibrillation 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

455 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record